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White spot syndrome virus (WSSV) is a major shrimp pathogen causing large economic losses. In an attempt to identify the envelope
proteins involved in virus infection, antisera against six WSSV envelope proteins were used in neutralization assays conducted in vivo. The
results showed that the virus infection could be significantly delayed or neutralized by antibodies against three WSSV envelope proteins
(VP68, VP281 and VP466). This neutralization was further confirmed by quantitative PCR. It could be concluded that the viral envelope
proteins VP68, VP281 and VP466 played roles in WSSV infection to shrimp.
D 2004 Elsevier Inc. All rights reserved.
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White spot syndrome virus (WSSV), first appearing in
the 1990s in Taiwan, has spread rapidly to shrimp-farming
areas all over the world and become one of the major
pathogens in cultured shrimp (Lo et al., 1996). It has a broad
host range, infecting all cultured shrimp as well as other
invertebrate aquatic organisms such as crab and crayfish
(Wang et al., 1998). The virus can cause 100% accumulative
mortality in 2–10 days to farmed shrimp. Therefore, WSSV
has attracted intensive investigations, resulting in some
exciting research progress in the past decade. Studies on
virus replication and viron morphogenesis show that DNA
replication and de novo envelope formation take place in the
nucleus (Durand et al., 1997; Wang et al., 2000). However,
the mechanism of WSSV entry into the shrimp cell and of
the spread of the virus in the crustacean body is still0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.12.011
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1 Equal contribution.unknown. It is believed that, of the viral structural proteins,
the envelope proteins play very important roles in virus
infection, such as recognition and attachment to receptors in
the host cell surface. In this context, with the completion of
the WSSV genomic DNA sequence (van Hulten et al.,
2001b; Yang et al., 2001), researches have now focused on
the analyses of envelope proteins (Zhang et al., 2004). Up to
date, six WSSV genes have been revealed to encode the
envelope proteins (Huang et al., 2002a, 2002b; Zhang et al.,
2002a, 2002b, 2004).
Antibodies raised against individual viral envelope
protein have been used successfully in neutralization assays
to identify envelope proteins involved in virus entry during
infection. Information derived from such assays has even
led to passive immunization strategies for vertebrates
(Martignoni et al., 1980; Schofield et al., 2000; van Hulten
et al., 2001a, 2001b; Volkman and Goldsmith, 1985). It is
showed that some neutralizing antibodies can bind to
envelop spikes on the viron and prevent the attachment of
the virus to the cell surface or virus uncoating (Burton et al.,
2000).05) 578–583
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in WSSV infection to shrimp, the neutralization experiments
of antibodies against six envelope proteins (VP22/VP26,
VP28, VP68, VP281, VP292 and VP466), as well as WSSV
virions, were performed in this investigation. The results
suggested that four envelope proteins (VP28, VP68, VP281
and VP466) might play key roles in the initial steps of
WSSV infection in shrimp.Results
Dosage of WSSV for shrimp infection
A WSSV stock was produced in P. monodon shrimp by
intramuscular injection of WSSV inoculum, which was
prepared from P. monodon shrimp with pathologically
confirmed infection. To determine the dilution resulting in
100% mortality in P. japonicus shrimp, an in vivo virus
titration was performed in triplicate. The results indicated
that 80–100% mortality occurred in all shrimp groups
infected with different copies of WSSV virions 14 days
post-infection (Fig. 1). However, the mortality varied among
groups with virus concentration, as expected. Dead shrimp
were confirmed for WSSV infection by PCR with WSSV-
specific primers (data not shown). Administration of 106
and 107 virus copies resulted in 100% mortality in a period
of 8 days. The mortalities for groups with 101 and 102 virus
copies were the lowest. A delay in 100% mortality was
observed when 103, 104 and 105 copies of virus were used.
The above experiments were repeated in triplicate yielding
essentially the same results. Based on the in vivo virus
titration, the WSSV inoculum with 106 virus copies was
used in subsequent experiments because it was expected to
give the optimal response to the neutralization in terms of
mortality.Fig. 1. Dosage of WSSV for shrimp infection. Days post-infection were
shown on the abscissa and accumulated mortality on the ordinate. Numbers
on the right indicated WSSV copies used in the infection. Each point
represented the mean of triplicate assays within F1% standard deviation.WSSV neutralization in vivo by antibodies
The antibodies against WSSV envelope proteins (VP22/
VP26, VP28, VP68, VP281, VP292 and VP466) and WSSV
virions, as well as a non-envelope protein (VP448) as
control, were used in the in vivo neutralization assays. After
incubations of WSSV with various antibodies, the mixtures
and eight antibodies (IgGs) only were injected into shrimp,
respectively. The results showed that the shrimp mortalities
were very low for the negative control (0.9% NaCl) and
eight IgGs only, whereas the shrimp from the positive
control (WSSV only) displayed 100% mortality at 8 days
post-infection (Fig. 2). This suggested that these antibodies
had no toxicity to shrimp. When the mixture of WSSV with
anti-VP68 IgG, anti-VP281 IgG, anti-VP466 IgG or anti-
WSSV IgG was injected into shrimp, respectively, the
shrimp mortality was significantly delayed (Fig. 2), indicat-
ing that the infection of WSSV could be delayed or
neutralized by antibodies against VP68, VP281, VP466 or
WSSV virions. Also the anti-VP28 IgG showed neutraliza-
tion effect on WSSV (data not shown), which was
consistent with the result as revealed by van Hulten et al.
(2001a). However, the shrimp, injected with the incubation
mixture of WSSV and anti-VP26 IgG, WSSV and anti-
VP292 IgG or WSSV and anti-VP448 IgG, showed the
similar result to that of the positive control (Fig. 2).
Apparently the antibodies against VP22/VP26, VP292 and
VP448 were not able to neutralize the virus.
WSSV detection by PCR
To test the WSSV infection in neutralization assays, PCR
and quantitative PCR were used to detect the virus in gills of
P. japonicus at various infection stages (2, 4, 6, 12, 24, 48
and 72 h post-infection). After infection, WSSV appeared in
shrimp from the first day for the positive control, as well as
for the mixture of WSSV with anti-VP26 IgG, anti-VP292
IgG or anti-VP448 IgG, respectively (data not shown). On
the other hand, WSSV, neutralized by anti-VP281 IgG, anti-
VP68 IgG, anti-VP466 IgG or anti-WSSV IgG, was
detected at 2 or 3 days post-infection (data not shown).
This clearly revealed that the infection of WSSV could be
significantly delayed by antibodies against envelope pro-
teins VP68, VP281 and VP466.
Based on the quantitative PCR analyses, for the positive
control, the copy of WSSV was approximately 105 virions
per mg gill tissues at 12 h post-infection and approximately
107 virions per mg tissues at 72 h post-infection (Fig. 3).
However, after pre-incubation of WSSV with the antibody
against VP281, the virus first appeared in gill at approx-
imately 105 copies/mg tissues at 48 h post-infection and
proliferated to approximately 106 copies/mg tissues at 72
post-infection (Fig. 3). Antibodies against VP68, VP466 or
WSSV virions yielded essentially the same results as that of
anti-VP281 IgG. When the virus was pre-incubated with the
antibodies against VP26, VP292 or VP448, the results were
Fig. 2. Neutralization of WSSV infection in P. japonicus by antibodies
against envelope proteins and WSSV virions. The solutions used for
injection were shown on the right. Each point represented the mean of
triplicate assays within F1% standard deviation.
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Therefore, it could be concluded that the infection of WSSV
was really delayed or neutralized by the antibodies against
VP68, VP281 or VP466.Discussion
WSSV, considered to be a new virus at present (Chen et
al., 1997), is the causative agent of a major pandemic thathas led to severe mortalities of cultured shrimp worldwide.
The virus can also infect other invertebrate aquatic
organisms (Lo et al., 1996). Therefore, WSSV is not only
a major threat to the shrimp industry, but also to the marine
environment. However, up to date, there is no efficient
method to control the virus. The WSSV particles are non-
occluded and bacilliform in shape with double envelopes
(Chen et al., 1997; Durand et al., 1997). For enveloped
virus, the viral envelope protein have key effects on the
virus infection, such as recognition and attachment to
receptors in the host cell surface, as well as fusion with
the host cell membrane during the virus assembly. In this
context, the researches should shifted towards the identi-
fication of envelope proteins involved in WSSV infection to
shrimp.
In our previous studies, six WSSV genes were found to
encode the envelope proteins (Zhang et al., 2004). In an
attempt to further identify the envelope proteins involved in
the WSSV infection, the in vivo neutralization experiment
with antibodies against these six WSSV envelope proteins
was conducted in this investigation due to the lack of a
suitable cell line to culture the virus. The results revealed
that the infection of WSSV could be significantly delayed
by VP68, VP281 and VP466 antibodies. These three
envelope proteins, as well as VP28 revealed by van Hulten
et al. (2001a), might play roles in the initial steps of WSSV
infection in shrimp and merit further study. They could be
the candidates for screening receptors in shrimp cell surface,
which will be helpful to realize the mechanism of the virus
infection and to control the infection of WSSV in shrimp
industry.
As indicated by the results in the present study, the
WSSV infection was only delayed by antibodies against
four envelope proteins (VP28, VP68, VP281 and VP466),
but not by antibodies against envelope proteins VP26 and
VP292. Considering that virions of WSSV are double-
enveloped as revealed by electron microscopy studies (Chen
et al., 1997; Durand et al., 1997), it might be inferred that
VP68, VP281 and VP466, as well asVP28, were located on
the virus surface and had key effects on the virus infection.
Although VP26 and VP292 proteins were also located in the
envelope of WSSV, they might be only structural proteins
which were not involved in the virus infection. In some
viruses, the neutralizing antibodies can bind to envelope
spikes on the virons. Therefore, it could be postulated that
the four envelope proteins (VP28, VP68, VP281 and
VP466) showing antibody neutralization were located in
the envelope spike of WSSV virions. However, The
difference between neutralizing and non-neutralizing enve-
lope proteins of WSSV is still unknown and remains to be
further studied.
Penaeid shrimp culture is an important economic
industry worldwide, which has suffered from white spot
syndrome these years. Up to date, however, no efficient
method has been found to prevent shrimp from the infection
of WSSV. In this case, the antibodies against WSSV
Fig. 3. Quantitative PCR of WSSV in gills. M: DNAmarker. Numbers indicated WSSV, copies. On the right, the solutions used for injection (WSSVor WSSV +
antisera), and times post-infection (12, 24, 48 and 72 h) were shown.
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this study, as well as VP28 indicated by van Hulten et al.
(2001a), could be used directly as a passive immune
strategy to control the WSSV infection in shrimp. This
promised to be a choice for the virus control in shrimp
industry at present.Materials and methods
Shrimp culture
Cultures of P. japonicus shrimp, approximately 10 g and
10–12 cm each, were performed keeping in groups of 20
W. Wu et al. / Virology 332 (2005) 578–583582individuals in 80-l aquariums at 25 8C. They were fed with
commercial diet at 5% of body weight before and during
experiments. Hemolymph and gill tissues from P. japonicus
shrimp were subjected at random to PCR detection with
WSSV-specific primers to ensure that they were WSSV-free
before experimental infection.
Shrimp white spot syndrome virus (WSSV) and WSSV
dosage for shrimp infection
The infected tissue from P. monodan shrimp with a
pathologically confirmed infection was homogenized in TN
buffer (20 mM Tris–HCl, 400 mM NaCl, pH 7.4) at 0.1 g/
ml. After centrifugation at 2000  g for 10 min, the
supernatant was diluted to 1:100 with 0.9% NaCl and
filtered through 0.45 Am filter. Then 0.1 ml of the filtrate
was injected intramuscularly into healthy P. japonicus
shrimp in the lateral area of the fourth abdominal segment
using a syringe with 29-gauge needle. Several days later, the
WSSV-infected moribund shrimp (confirmed by PCR) were
collected and stored at 70 8C as WSSV stock.
The WSSV stock was serially diluted to prepare various
copies of virus, which were determined by quantitative PCR
as described below. Subsequently, the WSSV inoculum with
different copy of virus (101, 102, 103, 104, 105, 106 and 107),
as well as the negative control (0.9% NaCl), were injected
intramuscularly into healthy P. japonicus shrimp in the
lateral area of the fourth abdominal segment at 0.1 ml/
shrimp, respectively. Twenty individuals of shrimp were
kept in each assay. During shrimp culture, the shrimp
mortality was monitored twice daily, and the dead shrimp
were examined by PCR to confirm the infection of WSSV.
Polyclonal antibodies against WSSV envelope proteins and
WSSV virions
The purification of WSSV using WSSV-infected cray-
fish Cambarus clarkii was conducted as described pre-
viously (Zhang et al., 2002a). The purified virions were
used as antigen to immunize mice by intradermal injection
once every 2 weeks over an 8-week period. Antigen (5 Ag)
was mixed with an equal volume of Freund’s complete
adjuvant for the first injection. Subsequent injections were
performed using 5 Ag of antigen mixed with an equal
volume of Freund’s incomplete adjuvant. Four days after
the last injection, mice were exsanguinated and the
polyclonal antisera collected. The titers of antisera were
about 1:20,000 as determined by enzyme-linked immuno-
sorbent assay (ELISA). The immunoglobulin (IgG) frac-
tions were purified by protein A-Sepharose (Bio-Rad) and
stored at 70 8C.
The polyclonal antibodies against six WSSV envelope
proteins (VP22/VP26, VP28, VP68, VP281, VP292 and
VP466) were obtained in our previous studies (Huang et al.,
2002a, 2002b; Zhang et al., 2002a, 2002b, 2004). They were
purified by protein A-Sepharose to get the IgG fractions. As anegative control, the antibody (IgG) against VP448, one of
the WSSV non-envelope proteins, was used. The anti-VP448
IgG was prepared as normal protocol.
Neutralization assay
Prior to injection into shrimp, antibodies (IgGs, 0.2 Ag/
Al) against VP22/VP26, VP28, VP68, VP281, VP292,
VP466, VP448 and WSSV virions were incubated respec-
tively with the WSSV (final concentration 107 virions/ml)
for 1 h at room temperature. Then the mixture of antibody
and WSSV was intramuscularly injected into P. japonicus in
the lateral area of the fourth abdominal segment at 0.1 ml/
shrimp using a syringe with 29-gauge needle. At the same
time, each of eight antibodies only, as well as a negative
control (0.9% NaCl) and a positive control (WSSV only),
was included in the injections. For each treatment, 20
shrimp were used. After injections, the shrimp were kept in
groups in 80-l aquariums at 25 8C. The shrimp mortality and
infection by WSSV were monitored daily. Everyday, three
shrimp specimens from each group of neutralization assays
were selected at random and subjected to PCR analysis. All
assays were carried out in triplicate.
WSSV detection and quantitative analysis by PCR
Twenty milligrams of gills was collected from shrimp and
homogenized in 500 Al of guanidine lysis buffer (50 mM
Tris–HCl, pH 8.0, 25 mM EDTA, 4 M guanidinium
thiocyanate, 0.5% N-lauroylarcosine) at room temperature.
After centrifugation at 15,000  g for 3 min, 20 Al of silica
were added into the supernatant for DNA absorption.
Subsequently, the mixture was rotated for 5 min, followed
by centrifugation at 15,000 g for 30 s. The pellet was rinsed
twice with 70% ethanol and resuspended in 20 Al distilled
water. Then it was centrifuged at 15,000  g for 2 min. The
supernatant was used as PCR template (Yang et al., 1997).
PCR was performed with two WSSV-specific primers
(forward primer 5V TATTGTCTCTCCTGACGTAC 3V and
reverse primer 5VCACATTCTTCACGAGT CTAC 3V). The
conditions for PCR amplification were as follows: 5min at 94
8C, 40 cycles at 94 8C for 45 s and 68 8C for 1 min and
extension at 68 8C for 5 min. For quantitative PCR, DNA
template and equal volume of internal standard plasmid
serially diluted in 10-folds were added to PCR reaction
solution (Wang et al., 1997), followed by PCR amplification
as described above. PCR products were analyzed by electro-
phoresis in 2% agarose gels stained with ethidium bromide
and visualized by ultraviolet transillumination.Acknowledgments
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